Zhou Chenliang, Wang Yiyun, Chen Zonghui, Qian Guowei, Yu Wenxi, Wang Yong, Zheng Shuier, Shen Zan, Li Hongtao, Wang Yonggang
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Department of Emergency, Shanghai United Family Hospital, Shanghai, China.
Front Oncol. 2022 Jun 16;12:926387. doi: 10.3389/fonc.2022.926387. eCollection 2022.
Totally implanted ports (PORTs) have been widely used among patients with malignancy. Cardiac metastasis secondary to bone sarcoma and catheter-related right atrial thrombosis (CRAT) can be both present as cardiac masses. However, these two cardiac masses share very similar imaging characteristics.
The features, treatments, and outcomes of 5 bone sarcoma pediatric patients with PORTs who suffered from cardiac masses in the right atrium were analyzed. Clinical data and histological characteristics of cardiac masses were also recorded.
Among 928 patients with malignancy and PORTs, 5 bone sarcoma pediatric patients were found to have cardiac masses in the right atrium. The catheter tips were located in the right atrium of 4 patients and the superior vena cava-right atrium junction (CAJ) of 1 patient. Four patients with good response to anti-tumor treatment had received surgical lumpectomies for pathologic identification and mass excision, with cardiac metastases among 1 patient and thromboses among 3 patients. The median time from venous access port implantation to cardiac mass detection for CRAT was 6.3 months (range: 4.7-6.8 months) and to diagnosis of or possible cardiac metastasis was 13.3 months (range: 11.2-15.4 months).
The placement of a catheter tip into the right atrium should be avoided. The time from PORTs implantation to cardiac mass detection might serve as a potential tool to differentiate cardiac metastasis from CRAT. Surgical management may be an effective treatment for bone sarcoma pediatric patients who had good response to anti-tumor treatment and suffered from cardiac masses in the right atrium.
全植入式端口(PORTs)已在恶性肿瘤患者中广泛使用。骨肉瘤继发的心脏转移和导管相关右心房血栓形成(CRAT)均可表现为心脏肿块。然而,这两种心脏肿块具有非常相似的影像学特征。
分析了5例患有PORTs且右心房出现心脏肿块的小儿骨肉瘤患者的特征、治疗方法及预后。还记录了心脏肿块的临床数据和组织学特征。
在928例患有恶性肿瘤并植入PORTs的患者中,发现5例小儿骨肉瘤患者右心房有心脏肿块。4例患者的导管尖端位于右心房,1例患者的导管尖端位于上腔静脉-右心房交界处(CAJ)。4例对抗肿瘤治疗反应良好的患者接受了手术肿块切除术以进行病理鉴定和肿块切除,其中1例为心脏转移,3例为血栓形成。CRAT从静脉通路端口植入到心脏肿块检测的中位时间为6.3个月(范围:4.7 - 6.8个月),到心脏转移诊断或可能的心脏转移的中位时间为13.3个月(范围:11.2 - 15.4个月)。
应避免将导管尖端放置在右心房。从PORTs植入到心脏肿块检测的时间可能是区分心脏转移和CRAT的潜在工具。对于对抗肿瘤治疗反应良好且右心房有心脏肿块的小儿骨肉瘤患者,手术治疗可能是一种有效的治疗方法。